Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206864 · ClinicalTrials.gov registry record · NA
Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults
A NA study, sponsored by Solarea Bio.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05206864 is a NA study that has completed, run by Solarea Bio. The registered enrollment target is 32 participants.
The verdict
NCT05206864, a NA study, has completed, sponsored by Solarea Bio.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.
Interventions
- OTHER Placebo
- OTHER Medical Food: SBD111
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-02-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05206864
The ClinicalTrials.gov registry entry for NCT05206864 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Solarea Bio, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05206864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05206864 about?
NCT05206864 is a clinical study titled "Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults". The aim of the trial is to determine if the synbiotic (prebiotic and probiotic), provided twice daily (capsule) is safe and tolerable in healthy adults.
What is the current status of trial NCT05206864?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2021-09-01. Estimated completion is 2022-02-05.
What interventions are being tested in trial NCT05206864?
The interventions under investigation include: Placebo (OTHER), Medical Food: SBD111 (OTHER).
Who is sponsoring clinical trial NCT05206864?
This trial is sponsored by Solarea Bio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.